Owen Mumford has been granted a patent for an innovative injection device designed to deliver medicament doses from a syringe. The device features a unique interlock mechanism that ensures safety by preventing accidental activation, allowing dose delivery only when properly positioned against the injection site. GlobalData’s report on Owen Mumford gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Owen Mumford, Wearable drug delivery devices was a key innovation area identified from patents. Owen Mumford's grant share as of June 2024 was 42%. Grant share is based on the ratio of number of grants to total number of patents.
Injection device with interlock for safe medicament delivery
The patent US12036393B2 describes an innovative injection device designed for the precise delivery of medicaments from a syringe. The device features a housing composed of a forward body and a rearward body that are axially interconnected, allowing for relative movement. A drive mechanism, including a plunger, is activated by a trigger to dispense the medicament. A critical safety feature is the interlock system, which has locked and unlocked positions. The interlock is engaged through axial movement of the forward and rearward bodies when the device is pressed against an injection site, preventing accidental activation of the drive mechanism until the device is properly positioned.
Further enhancements to the device include an interlock hold arrangement that utilizes interlocking components on both the forward and rearward bodies. This arrangement ensures that the device remains securely in place during use, with a resilient member and cam surface facilitating the engagement process. The design also incorporates a shroud assembly that is biased forward, allowing it to move rearward when pressure is applied against the skin. This mechanism not only aids in the activation of the interlock but also ensures that the device is ready for use only when correctly positioned. The patent outlines various configurations and features, including the use of flexible components and additional interlock arrangements, enhancing the device's functionality and safety during medicament delivery.
To know more about GlobalData’s detailed insights on Owen Mumford, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
